like pls
Longeveron ends record rally with appointment of new medical chief
ValleraTo/iStock via Getty Images After sharp gains last week, the clinical-stage biotech, Longeveron closed lower for the second straight session on Tuesday after the company announced the appointment of Chris Min as its Chief Medical Officer . Longeveron shares recorded the third-best weekly gain last week on the back of peer-reviewed data on its Alzheimer’s disease candidate Lomecel-B. In an announcement Tuesday, the company said that its global R&D efforts would be led by Dr. Min effec
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Like
Report
Login to post
No comments yet